Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 11:22 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2185–2208 of 196,794 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: ALL Clear all

Conditions: Solid Tumor, Advanced Cancer, Metastatic Cancer, Gastric Cancer, Gastroesophageal Junction Carcinoma, Esophageal Adenocarcinoma, PDAC - Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer (BTC)
Interventions: TJ033721 (givastomig), TJ033721 (givastomig) , nivolumab, chemotherapy, TJ033721 (givastomig), chemotherapy, TJ033721 (givastomig), durvalumab, chemotherapy; Drug
Lead sponsor: I-Mab Biopharma US Limited; Industry
Eligibility: 18 Years and older
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 11
States / cities: Orange, California • Aurora, Colorado • Layfayette, Indiana + 7 more

Conditions: Pain
Interventions: Not listed
Lead sponsor: Defense and Veterans Center for Integrative Pain Management; Other
Eligibility: 18 Years to 89 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Peri-implant Mucositis, Gingivitis
Interventions: interruption of oral hygiene; Behavioral
Lead sponsor: UConn Health; Other
Eligibility: 21 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Stroke
Interventions: tDCS; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Muscular Hypertrophy
Interventions: high protein milk, Placebo; Dietary Supplement
Lead sponsor: Marymount University; Other
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Arlington, Virginia

Conditions: Neuroblastoma
Interventions: Dinutuximab with Chemotherapy; Drug
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 1 Year and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 7
States / cities: Los Angeles, California • Aurora, Colorado • Atlanta, Georgia + 4 more

Conditions: Age-associated Memory Impairment
Interventions: Brainphyt high dose, Placebo; Dietary Supplement
Lead sponsor: Microphyt; Industry
Eligibility: 55 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: College Station, Texas

Conditions: Patients Receiving Fractionated Stereotactic Radiotherapy, for Brain Tumors
Interventions: GTC frame, Thermoplastic facemask, Stereotactic radiation therapy; Device · Radiation
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Acute Pain
Interventions: 2 mg IV hydromorphone; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 21 Years to 65 Years
Enrollment: 298 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Sexual Risk Behavior for HIV-infection, Reproductive Health
Interventions: PrEP Decision Aid, Generic Information; Device · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Down Syndrome, Cognitive Dysfunction
Interventions: Aricept (Donepezil hydrochloride), Placebo; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 6 Years to 10 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 2
States / cities: San Antonio, Texas • Herndon, Virginia

Conditions: Breastfeeding
Interventions: Not listed
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 3
States / cities: Tampa, Florida

Conditions: Diabetes Mellitus, Chronic Disease
Interventions: Text Messaging (TM), Health Coaching (HC), Enhanced Usual Care (EC); Behavioral
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years and older
Enrollment: 646 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 19
States / cities: Holly Springs, Mississippi • Bartlett, Tennessee • Covington, Tennessee + 2 more

Conditions: HIV Prevention
Interventions: SBCM-PrEP, CDC-PrEP; Behavioral
Lead sponsor: Hilary L Surratt, PhD; Other
Eligibility: 18 Years to 99 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Diabetes
Interventions: Standard ONS, Diabetes specific ONS 1, Diabetes specific ONS 2; Other
Lead sponsor: Abbott Nutrition; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Chicago, Illinois • Cincinnati, Ohio

Conditions: Cancer, Chemotherapy
Interventions: Virtual reality therapy, Questionnaires, Measure heart rate, Cyber sickness measurement; Behavioral · Procedure
Lead sponsor: Cody Stansel; Other
Eligibility: 18 Years and older
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Healthy, Cognitive Change, Effects of External Neurostimulation on Cognition
Interventions: Active Neurostimulation, Sham Stimulation; Device
Lead sponsor: OpenBCI; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Aortic Aneurysm, Abdominal
Interventions: Medical imaging; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 80 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Rett Syndrome
Interventions: Lovastatin; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 3 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Memory, Delayed
Interventions: Deep Brain Stimulation, Memory and spatial navigation tasks, Physiological Signals, Questionnaires and Assessments; Device · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 2
States / cities: Los Angeles, California • Durham, North Carolina

Conditions: Healthy, Stroke, Normal Physiology, Aging
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 114 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2030
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Bipolar Disorder
Interventions: Ramelteon, Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 535 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 41
States / cities: Birmingham, Alabama • Anaheim, California • Glendale, California + 38 more

Conditions: Metastatic Bladder Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Refractory Bladder Urothelial Carcinoma, Refractory Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v8
Interventions: Biospecimen Collection, Bone Scan, Computed Tomography, Docetaxel, Eribulin Mesylate, Gemcitabine Hydrochloride, Magnetic Resonance Imaging, Paclitaxel, Sacituzumab Govitecan; Procedure · Drug · Biological
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 448
States / cities: Kingman, Arizona • Phoenix, Arizona • Fort Smith, Arkansas + 306 more

Conditions: Dry Eye
Interventions: Determine the ability of the TearScience™ LipiView™ II Ocular Surface Interferometer and the Keratograph® 5M to detect tear film stability utilizing Miebo®; Drug
Lead sponsor: The Eye Care Institute; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Louisville, Kentucky

Search by objective public record fields.

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

SEXI: Sciatic Expression and Identification of Differential Proteins in Traumatized Versus Nontraumatized Nerves

Experimental Peri-implant Mucositis in Humans

Transcranial Direct Current Stimulation (tDCS) in Chronic Stroke Recovery

Resistance Training and Milk Supplementation

Rapid Administration Pilot for Infusing Dinutuximab

Effect of BrainPhyt High Dose on Cognitive Function in Healthy Older Individuals

Comparing Two Forms of Head Immobilization for Stereotactic Radiotherapy

Safety of Hydromorphone in Adult Patients Presenting to the Emergency Department With Acute Severe Pain

Integrating PrEP Decision Making Into Counseling in Sexual and Reproductive Health Clinics

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10

Predictors of Lactogenesis II

The Management of Diabetes in Everyday Life Program

Integrated PrEP Interventions for People Who Inject Drugs in Rural Kentucky

Effect of Nutritional Products in Subjects With Type 2 Diabetes

Virtual Reality on Pain, Stress, and Affect in the Infusion Clinic

Cognitive Augmentation Via Multimodal Sensing and Auricular Neurostimulation

Predicting Rupture of AAA by Anatomic and Hemodynamic Markers

Pharmacological Treatment of Rett Syndrome With Statins

Neural Correlates of Real World Spatial Navigation in Humans

Influence of Brain Oscillation-Dependent TMS on Motor Function

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer

A Single Center, Open-Label Study to Evaluate the Ability of the TearScience™ LipiView™ II Ocular Surface Interferometer and the Keratograph® 5M to Detect Tear Film Stability Utilizing Miebo®